Recent News for CYTK - Cytokinetics, Incorporated

Date Title
Dec 5 Cytokinetics Announces New Results Presented at the International Symposium on ALS/MND
Dec 5 The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission
Dec 1 The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Nov 27 Cytokinetics to Participate in the Piper Jaffray Healthcare Conference
Nov 27 5 “Strong Buy” Biotech Stocks With More Than 80% Upside
Nov 26 Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND
Nov 19 Urban Outfitters leads after hour losers
Nov 18 New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function
Nov 18 New Results From COSMIC-HF Presented At AHA 2019 Show Treatment Of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral Or Improved Measures Of Diastolic Function
Nov 11 Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the American Heart Association Scientific Sessions 2019
Nov 8 Cytokinetics prices convertible debt offering; shares down 2%
Nov 8 Cytokinetics Announces Pricing of Public Offering of Convertible Senior Notes
Nov 7 Mixed shelf roundup - healthcare
Nov 6 Cytokinetics Announces Proposed Public Offering of Convertible Senior Notes
Nov 6 Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT
Nov 5 Cytokinetics to Participate in the Credit Suisse 28th Annual Healthcare Conference
Nov 3 Cytokinetics, Incorporated (CYTK) CEO Robert Blum on Q3 2019 Results - Earnings Call Transcript
Nov 1 Cytokinetics, Incorporated 2019 Q3 - Results - Earnings Call Presentation
Nov 1 Here is What Hedge Funds Really Think About Cytokinetics, Incorporated (CYTK)
Oct 31 Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates
Oct 31 Cytokinetics EPS misses by $0.01, misses on revenue
Oct 31 Cytokinetics Reports Third Quarter 2019 Financial Results
Oct 24 Cytokinetics to Announce Third Quarter Results on October 31, 2019
Oct 17 Should You Worry About Cytokinetics, Incorporated's (NASDAQ:CYTK) CEO Pay?
Oct 4 Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting

Back to the Main CYTK Page...